îæ€çŽ¢
îæ€çŽ¢
î
Monte Rosa Therapeutics Inc
GLUEîãŠã©ãããªã¹ãã«è¿œå
16.520USD
-6.160-27.16%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
1.40Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-31Monte Rosa Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.67ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯385瀟äž74äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯18.00ã§ãæé«ã¯20.00ãæäœã¯13.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
9
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
33.600
ç®æšæ ªäŸ¡
+103.39%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
496
åèš
6
äžå€®å€
7
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Monte Rosa Therapeutics Inc
GLUE
9
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Monte Rosa Therapeutics Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îMonte Rosa Therapeutics Inc ã®äºæ³åç㯠5.52M ã§ãã
Monte Rosa Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãMonte Rosa Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 18.00 ãšäºæ³ããæé«äºæ³ã¯ USD 20.00ãæäœäºæ³ã¯ USD 13.00 ãšäºæ³ããŠããŸãã
Monte Rosa Therapeutics IncGLUE ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.45 ã§ããããMonte Rosa Therapeutics IncGLUE ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.54 ã§ããã次ã®ååæã® EPS 㯠USD -0.38 ãšäºæ³ãããŸãã
Monte Rosa Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î9 ã¢ããªã¹ãã«ãã Monte Rosa Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Monte Rosa Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã